Anders Höög

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2022;61(5):140
Altered expression of the IGF2-H19 locus and mitochondrial respiratory complexes in adrenocortical carcinoma
Scicluna P; Caramuta S; Kjellin H; Xu C; Froebom R; Akhtar M; Gao J; Shi H; Kjellman M; Almgren M; Hoog A; Zedenius J; Ekstroem TJ; Braenstroem R; Lui W-O; Larsson C
Article: ENDOCRINE PATHOLOGY. 2022;33(2):231-242
Prognostic Utility of the Ki-67 Labeling Index in Follicular Thyroid Tumors: a 20-Year Experience from a Tertiary Thyroid Center
Hellgren LS; Stenman A; Paulsson JO; Hoog A; Larsson C; Zedenius J; Juhlin CC
Article: HEAD AND NECK PATHOLOGY. 2021;15(2):628-637
Perithyroidal Salivary Gland Acinic Cell Carcinoma: Morphological and Molecular Attributes of a Unique Lesion
Juhlin CC; Asa SL; Jatta K; Rodsari HN; Shabo I; Haglund F; Delahunt B; Samaratunga H; Egevad L; Hoog A; Zedenius J
Article: JOURNAL OF CLINICAL PATHOLOGY. 2021;75(10):jclinpath-2021-207631-662
Nuclear-specific accumulation of telomerase reverse transcriptase (TERT) mRNA in TERT promoter mutated follicular thyroid tumours visualised by in situ hybridisation: a possible clinical screening tool?
Hellgren LS; Olsson A; Kaufeldt A; Paulsson JO; Hysek M; Stenman A; Zedenius J; Larsson C; Hoog A; Juhlin CC
Article: ENDOCRINE PATHOLOGY. 2020;31(4):401-410
Clinical Routine Application of the Second-generation Neuroendocrine Markers ISL1, INSM1, and Secretagogin in Neuroendocrine Neoplasia: Staining Outcomes and Potential Clues for Determining Tumor Origin
Juhlin CC; Zedenius J; Hoog A
Article: ENDOCRINE PATHOLOGY. 2020;31(2):156-165
Lipoadenoma of the Parathyroid Gland: Characterization of an Institutional Series Spanning 28 Years
Juhlin CC; Falhammar H; Zedenius J; Nilsson I-L; Hoog A
Article: INTERNATIONAL JOURNAL OF CANCER. 2020;146(6):1652-1666
Merkel cell polyomavirus oncoproteins induce microRNAs that suppress multiple autophagy genes
Kumar S; Xie H; Shi H; Gao J; Juhlin CC; Bjornhagen V; Hoog A; Lee L; Larsson C; Lui W-O
Article: DIAGNOSTIC PATHOLOGY. 2019;14(1):127
Signet ring cell variant of follicular thyroid carcinoma: Report of two cases with focus on morphological, expressional and genetic characteristics
Hysek M; Jatta K; Stenman A; Darai-Ramqvist E; Zedenius J; Hoog A; Juhlin CC
Article: CANCERS. 2019;11(10):E1443-1443
Clinical Routine TERT Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic Disease
Hysek M; Paulsson JO; Jatta K; Shabo I; Stenman A; Hoog A; Larsson C; Zedenius J; Juhlin CC
Article: INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY. 2019;27(6):658-663
Clear Cell Variant of Papillary Thyroid Carcinoma With Associated Anaplastic Thyroid Carcinoma: Description of an Extraordinary Case
Juhlin CC; Hoog A
Article: MODERN PATHOLOGY. 2019;32(8):1082-1094
Parafibromin immunostainings of parathyroid tumors in clinical routine: a near-decade experience from a tertiary center
Juhlin CC; Nilsson I-L; Lagerstedt-Robinson K; Stenman A; Branstrom R; Tham E; Hoog A
Article: INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY. 2019;27(3):290-293
Clear Cell Variant of a Follicular Thyroid Tumor With Uncertain Malignant Potential: A Case Report
Juhlin CC; Brenstrom R; Shabo I; Hoog A
Article: ENDOCRINE PATHOLOGY. 2018;29(4):365-368
Solid Cell Nests Within a Parathyroid GlandReport of an Exceptional Case
Juhlin CC; Nilsson I-L; Hoog A
Article: CANCERS. 2018;10(11):E443-443
MiR-375 Regulation of LDHB Plays Distinct Roles in Polyomavirus-Positive and -Negative Merkel Cell Carcinoma
Kumar S; Xie H; Scicluna P; Lee L; Bjornhagen V; Hoog A; Larsson C; Lui W-O
Article: NEUROENDOCRINOLOGY LETTERS. 2018;39(4):305-309
Regional differences in somatostatin receptor 2 (SSTR2) immunoreactivity is coupled to level of bowel invasion in small intestinal neuroendocrine tumors
Fotouhi O; Zedenius J; Hoog A; Juhlin CC
Article: AUTOIMMUNITY. 2018;51(6):310-318
Active NET formation in Libman-Sacks endocarditis without antiphospholipid antibodies: A dramatic onset of systemic lupus erythematosus
Appelgren D; Dahle C; Knopf J; Bilyy R; Vovk V; Sundgren PC; Bengtsson AA; Wettero J; Munoz LE; Herrmann M; Hoog A; Sjowall C
Article: MOLECULAR AND CELLULAR ENDOCRINOLOGY. 2018;470:84-95
Molecular profiles of oxyphilic and chief cell parathyroid adenoma
Lu M; Kjellin H; Fotouhi O; Lee L; Nilsson I-L; Haglund F; Hoog A; Lehtio J; Larsson C
Article: CLINICAL GENITOURINARY CANCER. 2018;16(3):e517-e520
Somatostatin Receptor Expression in Renal Cell Carcinoma-A New Front in the Diagnostics and Treatment of Renal Cell Carcinoma
Hoog A; Kjellman M; Mattsson P; Juhlin CC; Shabo I
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2017;177(6):445-453
Inflammatory infiltrates in parathyroid tumors
Haglund F; Hallstrom BM; Nilsson I-L; Hoog A; Juhlin CC; Larsson C
Article: ENDOCRINE PATHOLOGY. 2016;27(4):346-351
Detailed Lymph Node Sectioning of Papillary Thyroid Carcinoma Specimen Increases the Number of pN1a Patients
Haglund F; Garvin S; Ihre-Lundgren C; Nilsson I-L; Hall E; Carling T; Hoog A; Juhlin CC
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2016;101(10):3616-3627
Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors
Fotouhi O; Kjellin H; Larsson C; Hashemi J; Barriuso J; Juhlin CC; Lu M; Hoog A; Pastrian LG; Lamarca A; Heredia Soto V; Zedenius J; Mendiola M; Lehtio J; Kjellman M
Article: ENDOCRINE. 2016;53(2):505-511
Minimally invasive follicular thyroid carcinomas: prognostic factors
Stenson G; Nilsson I-L; Mu N; Larsson C; Lundgren CI; Juhlin CC; Hoog A; Zedenius J
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2016;174(5):583-590
Diffuse PTH expression in parathyroid tumors argues against important functional tumor subclones
Haglund F; Juhlin CC; Kiss NB; Larsson C; Nilsson I-L; Hoog A
Article: CLINICAL ENDOCRINOLOGY. 2015;82(5):639-647
Primary aldosteronism: functional histopathology and long-term follow-up after unilateral adrenalectomy
Volpe C; Hamberger B; Hoog A; Mukai K; Calissendorff J; Wahrenberg H; Zedenius J; Thoren M
Article: HUMAN MOLECULAR GENETICS. 2015;24(8):2318-2329
Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing
Kunstman JW; Juhlin CC; Goh G; Brown TC; Stenman A; Healy JM; Rubinstein JC; Choi M; Kiss N; Nelson-Williams C; Mane S; Rimm DL; Prasad ML; Hoog A; Zedenius J; Larsson C; Korah R; Lifton RP; Carling T
Article: ENDOCRINE CONNECTIONS. 2015;4(1):76-85
Tumour nuclear oestrogen receptor beta 1 correlates inversely with parathyroid tumour weight
Haglund F; Rosin G; Nilsson I-L; Juhlin CC; Pernow Y; Norenstedt S; Dinets A; Larsson C; Hartman J; Hoog A
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2015;100(3):E493-E502
Whole-Exome Sequencing Characterizes the Landscape of Somatic Mutations and Copy Number Alterations in Adrenocortical Carcinoma
Juhlin CC; Goh G; Healy JM; Fonseca AL; Scholl UI; Stenman A; Kunstman JW; Brown TC; Overton JD; Mane SM; Nelson-Williams C; Backdahl M; Suttorp A-C; Haase M; Choi M; Schlessinger J; Rimm DL; Hoog A; Prasad ML; Korah R; Larsson C; Lifton RP; Carling T
Article: PLOS ONE. 2015;10(5):e0126472
Differential Protein Expression Profiles of Cyst Fluid from Papillary Thyroid Carcinoma and Benign Thyroid Lesions
Dinets A; Pernemalm M; Kjellin H; Sviatoha V; Sofiadis A; Juhlin CC; Zedenius J; Larsson C; Lehtio J; Hoog A
Article: CLINICAL CANCER RESEARCH. 2014;20(22):5733-5744
Human Anaplastic Thyroid Carcinoma Cells Are Sensitive to NK Cell-Mediated Lysis via ULBP2/5/6 and Chemoattract NK Cells
Wennerberg E; Pfefferle A; Ekblad L; Yoshimoto Y; Kremer V; Kaminskyy VO; Juhlin CC; Hoog A; Bodin I; Svjatoha V; Larsson C; Zedenius J; Wennerberg J; Lundqvist A
Article: ONCOTARGET. 2014;5(20):10048-10057
TERT promoter mutations and gene amplification: Promoting TERT expression in Merkel cell carcinoma
Xie H; Liu T; Wang N; Bjornhagen V; Hoog A; Larsson C; Lui W-O; Xu D
Article: CANCER. 2014;120(19):2965-2979
TERT Promoter Mutation as an Early Genetic Event Activating Telomerase in Follicular Thyroid Adenoma (FTA) and Atypical FTA
Wang N; Liu T; Sofiadis A; Juhlin CC; Zedenius J; Hoog A; Larsson C; Xu D
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2014;99(8):E1571-E1579
Telomerase-Dependent and Independent Telomere Maintenance and its Clinical Implications in Medullary Thyroid Carcinoma
Wang N; Xu D; Sofiadis A; Hoog A; Vukojevic V; Backdahl M; Zedenius J; Larsson C
Article: EPIGENETICS. 2014;9(7):987-997
Global hypomethylation and promoter methylation in small intestinal neuroendocrine tumors An in vivo and in vitro study
Fotouhi O; Fahmideh MA; Kjellman M; Sulaiman L; Hoog A; Zedenius J; Hashemi J; Larsson C
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2014;99(7):E1352-E1360
Rare Germline Mutations Identified by Targeted Next-Generation Sequencing of Susceptibility Genes in Pheochromocytoma and Paraganglioma
Welander J; Andreasson A; Juhlin CC; Wiseman RW; Backdahl M; Hoog A; Larsson C; Gimm O; Soderkvist P
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2014;170(4):583-591
MicroRNA expression patterns associated with hyperfunctioning and non-hyperfunctioning phenotypes in adrenocortical adenomas
Velazquez-Fernandez D; Caramuta S; Ozata DM; Lu M; Hoog A; Backdahl M; Larsson C; Lui W-O; Zedenius J
Article: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2014;134(2):507-517
MicroRNA Expression Patterns Related to Merkel Cell Polyomavirus Infection in Human Merkel Cell Carcinoma
Xie H; Lee L; Caramuta S; Hoog A; Browaldh N; Bjornhagen V; Larsson C; Lui W-O
Article: PLOS ONE. 2014;9(2):e87951
Differentially Expressed Proteins in Malignant and Benign Adrenocortical Tumors
Kjellin H; Johansson H; Hoog A; Lehtio J; Jakobsson P-J; Kjellman M
Article: EPIGENETICS. 2013;8(12):1347-1354
The VHL gene is epigenetically inactivated in pheochromocytomas and abdominal paragangliomas
Andreasson A; Kiss NB; Caramuta S; Sulaiman L; Svahn F; Backdahl M; Hoog A; Juhlin CC; Larsson C
Article: BIOPRESERVATION AND BIOBANKING. 2013;11(6):366-370
Long-Term Storage of Endocrine Tissues at-80°C Does Not Adversely Affect RNA Quality or Overall Histomorphology
Andreasson A; Kiss NB; Juhlin CC; Hoog A
Article: BMC CANCER. 2013;13:505
Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization
Hashemi J; Fotouhi O; Sulaiman L; Kjellman M; Hoog A; Zedenius J; Larsson C
Article: ENDOCRINE-RELATED CANCER. 2013;20(4):551-564
Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma
Caramuta S; Lee L; Ozata DM; Akcakaya P; Xie H; Hoog A; Zedenius J; Backdahl M; Larsson C; Lui W-O
Article: JOURNAL OF CLINICAL PATHOLOGY. 2013;66(4):351-354
Immunohistochemistry improves histopathologic diagnosis in primary aldosteronism
Volpe C; Hoog A; Ogishima T; Mukai K; Lu M; Thoren M; Hamberger B
Article: ENDOCRINE-RELATED CANCER. 2013;20(1):65-78
Acquired hypermethylation of the P16^INK4A promoter in abdominal paraganglioma: relation to adverse tumor phenotype and predisposing mutation
Kiss NB; Muth A; Andreasson A; Juhlin CC; Geli J; Backdahl M; Hoog A; Wangberg B; Nilsson O; Ahlman H; Larsson C
Article: JOURNAL OF SURGICAL ONCOLOGY. 2012;106(8):981-986
Anaplastic carcinoma of the thyroid gland: Treatment and outcome over 13 years at one institution
Segerhammar I; Larsson C; Nilsson I-L; Backdahl M; Hoog A; Wallin G; Foukakis T; Zedenius J
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2012;97(12):4631-4639
Evidence of a Functional Estrogen Receptor in Parathyroid Adenomas
Haglund F; Ma R; Huss M; Sulaiman L; Lu M; Nilsson I-L; Hoog A; Juhlin CC; Hartman J; Larsson C
Article: NEUROPEPTIDES. 2012;46(5):195-201
Galanin and its three receptors in human pituitary adenoma
Tofighi R; Barde S; Palkovits M; Hoog A; Hokfelt T; Ceccatelli S; Hulting A-L
Article: FAMILIAL CANCER. 2012;11(3):355-362
Molecular characterization of parathyroid tumors from two patients with hereditary colorectal cancer syndromes
Andreasson A; Sulaiman L; do Vale S; Martins JM; Ferreira F; Miltenberger-Miltenyi G; Batista L; Haglund F; Bjorck E; Nilsson I-L; Hoog A; Larsson C; Juhlin CC
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2012;166(6):1049-1060
Clinical, genetic, and immunohistochemical characterization of 70 Ukrainian adult cases with post-Chornobyl papillary thyroid carcinoma
Dinets A; Hulchiy M; Sofiadis A; Ghaderi M; Hoog A; Larsson C; Zedenius J
Article: ENDOCRINE-RELATED CANCER. 2012;19(3):389-407
Genetic characterization of large parathyroid adenomas
Sulaiman L; Nilsson I-L; Juhlin CC; Haglund F; Hoog A; Larsson C; Hashemi J
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2012;166(4):657-667
Proteomic profiling of follicular and papillary thyroid tumors
Sofiadis A; Becker S; Hellman U; Hultin-Rosenberg L; Dinets A; Hulchiy M; Zedenius J; Wallin G; Foukakis T; Hoog A; Auer G; Lehtio J; Larsson C
Article: PLOS ONE. 2012;7(5):e36448
Prolactin Receptor in Primary Hyperparathyroidism - Expression, Functionality and Clinical Correlations
Haglund F; Lu M; Vukojevic V; Nilsson I-L; Andreasson A; Dzabic M; Branstrom R; Hoog A; Juhlin CC; Larsson C
Article: ENDOCRINE-RELATED CANCER. 2011;18(6):643-655
The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma
Ozata DM; Caramuta S; Velazquez-Fernandez D; Akcakaya P; Xie H; Hoog A; Zedenius J; Backdahl M; Larsson C; Lui W-O
Article: VIRCHOWS ARCHIV. 2011;459(1):47-53
Absence of nucleolar parafibromin immunoreactivity in subsets of parathyroid malignant tumours
Juhlin CC; Haglund F; Obara T; Arnold A; Larsson C; Hoog A
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2011;108(26):10685-10689
Lowering apolipoprotein CIII delays onset of type 1 diabetes
Holmberg R; Refai E; Hoog A; Crooke RM; Graham M; Olivecrona G; Berggren P-O; Juntti-Berggren L
Article: JOURNAL OF ENDOCRINOLOGY. 2011;208(1):31-39
Calmodulin and calmodulin-dependent protein kinase II inhibit hormone secretion in human parathyroid adenoma
Lu M; Berglund E; Larsson C; Hoog A; Farnebo L-O; Branstrom R
Article: THYROID. 2010;20(10):1067-1076
Proteomic Study of Thyroid Tumors Reveals Frequent Up-Regulation of the Ca²⁺-Binding Protein S100A6 in Papillary Thyroid Carcinoma
Sofiadis A; Dinets A; Orre LM; Branca RM; Juhlin CC; Foukakis T; Wallin G; Hoog A; Hulchiy M; Zedenius J; Larsson C; Lehtio J
Article: JOURNAL OF MEDICAL CASE REPORTS. 2010;4:315
Electrical short-circuit in β-cells from a patient with non-insulinoma pancreatogenous hypoglycemic syndrome (NIPHS): a case report.
Bränström R; Berglund E; Curman P; Forsberg L; Höög A; Grimelius L; Berggren P-O; Mattsson P; Hellman P; Juntti-Berggren L
Article: ENDOCRINE PATHOLOGY. 2010;21(3):166-177
Parafibromin and APC as Screening Markers for Malignant Potential in Atypical Parathyroid Adenomas
Juhlin CC; Nilsson I-L; Johansson K; Haglund F; Villablanca A; Hoog A; Larsson C
Article: JOURNAL OF MOLECULAR ENDOCRINOLOGY. 2010;44(5):285-294
Expression and association of TRPC subtypes with Orai1 and STIM1 in human parathyroid
Lu M; Branstrom R; Berglund E; Hoog A; Bjorklund P; Westin G; Larsson C; Farnebo L-O; Forsberg L
Article: PLOS ONE. 2010;5(3):e9472
Frequent Promoter Hypermethylation of the APC and RASSF1A Tumour Suppressors in Parathyroid Tumours
Juhlin CC; Kiss NB; Villablanca A; Haglund F; Nordenstrom J; Hoog A; Larsson C
Article: JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. 2009;32(10):810-815
Increased ratio of mRNA expression of the genes CYP17 and CYP11B1 indicates autonomous cortisol production in adrenocortical tumors
Enberg U; Hennings J; Volpe C; Hellman P; Hoog A; Hamberger B; Thoren M
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2009;161(1):141-152
Transcriptional profiling enables molecular classification of adrenocortical tumours
Laurell C; Velazquez-Fernandez D; Lindsten K; Juhlin C; Enberg U; Geli J; Hoog A; Kjellman M; Lundeberg J; Hamberger B; Larsson C; Nilsson P; Backdahl M
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2009;35(2):369-374
Diagnostic and prognostic potential of MIB-1 proliferation index in thyroid fine needle aspiration biopsy
Sofiadis A; Tani E; Foukakis T; Kjellman P; Skoog L; Hoog A; Wallin G; Zedenius J; Larsson C
Article: AMERICAN JOURNAL OF CLINICAL PATHOLOGY. 2008;130(3):375-381
Quantitative assessment of the subepithelial collagen band does not increase the accuracy of diagnosis of collagenous colitis
Rubio CA; Orrego A; Hoog A; Porwitz A; F'etersson F; Elmberger G; Glaessgen A; Eriksson E; Kanter L; Jaremko G; Egevad L; Laforga J; Liljefors M; Lofdahl B; Norman P; Larsson O; Wanat R; Wejde J; Zickert P; Bjork J; Caini S; Palli D; Nesi G
Article: CANCER RESEARCH. 2008;68(17):7156-7164
CREB3L2-PPARγ fusion mutation identifies a thyroid signaling pathway regulated by intramembrane proteolysis
Lui W-O; Zeng L; Rehmann V; Deshpande S; Tretiakova M; Kaplan EL; Leibiger I; Leibiger B; Enberg U; Hoog A; Larsson C; Kroll TG
Article: ENDOCRINE-RELATED CANCER. 2008;15(3):801-815
Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinoma
Lee J-J; Au AYM; Foukakis T; Barbaro M; Kiss N; Clifton-Bligh R; Staaf J; Borg A; Delbridge L; Robinson BG; Wallin G; Hoog A; Larsson C
Article: MOLECULAR AND CELLULAR ENDOCRINOLOGY. 2008;287(1-2):72-80
Heterogeneous expression of SNARE proteins SNAP-23, SNAP-25, syntaxin1 and VAMP in human parathyroid tissue
Lu M; Forsberg L; Hoog A; Juhlin CC; Vukojevic V; Larsson C; Conigrave AD; Delbridge LW; Gill A; Bark C; Farnebo L-O; Branstrom R
Article: ENDOCRINE-RELATED CANCER. 2008;15(2):609-621
Methylation of the p16^INK4A promoter is associated with malignant behavior in abdominal extra-adrenal paragangliomas but not pheochromocytomas
Kiss NB; Geli J; Lundberg F; Avci C; Velazquez-Fernandez D; Hashemi J; Weber G; Hoog A; Ekstrom TJ; Backdahl M; Larsson C
Article: INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY. 2008;1(4):376-380
The Clinical Significance of Massive Intratumoral Lymphocytosis in Squamous Cell Carcinoma of the Anus
Rubio CA; Nilsson PJ; Petersson F; Hoog A; Blegen H; Chetty R
Article: ANTICANCER RESEARCH. 2007;27(6C):4431-4434
Further studies on serrated neoplasias of the cardia:: A review and case report
Rubio CA; Petersson F; Hoeoeg A; Jonasson JG; Nesi G; Chandanos E; Lindblad M
Article: ENDOCRINE-RELATED CANCER. 2007;14(2):501-512
Parafibromin immunoreactivity:: its use as an additional diagnostic marker for parathyroid tumor classification
Juhlin CC; Villablanca A; Sandelin K; Haglund F; Nordenstroem J; Forsberg L; Branstrom R; Obara T; Arnold A; Larsson C; Hoog A
Article: ENDOCRINE-RELATED CANCER. 2007;14(2):381-391
A PCR-based expression signature of malignancy in follicular thyroid tumors
Foukakis T; Gusnanto A; Au AYM; Hoog A; Lui W-O; Larsson C; Wallin G; Zedenius J
Article: THYROID. 2007;17(4):289-301
Molecular cytogenetic profiles of novel and established human anaplastic thyroid carcinoma models
Lee J-J; Foukakis T; Hashemi J; Grimelius L; Heldin N-E; Wallin G; Rudduck C; Lui W-O; Hoog A; Larsson C
Article: ENDOCRINE-RELATED CANCER. 2007;14(1):125-134
The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma
Geli J; Kiss N; Lanner F; Foukakis T; Natalishvili N; Larsson O; Kogner P; Hoog A; Clark GJ; Ekstrom TJ; Backdahl M; Farnebo F; Larsson C
Article: JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. 2007;30(2):153-162
Lymphocytic hypophysitis:: Report of two biopsy proven cases and one suspected case with pituitary autoantibodies
Bensing S; Hulting A-L; Hoog A; Ericson K; Kampe O
Article: JOURNAL OF BIOTECHNOLOGY. 2006;126(4):582-586
Pre-fractionation of archival frozen turnours for proteomics applications
Forsberg L; Larsson C; Sofiadis A; Lewensohn R; Hoog A; Lehtio J
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2006;29(5):1173-1182
A dog pedigree with familial medullary thyroid cancer
Lee J-J; Larsson C; Lui W-O; Hoog A; Von Euler H
Article: ANTICANCER RESEARCH. 2006;26(6C):4895-4899
Reliability of the reported size of removed colorectal polyps
Rubio CA; Grimelius L; Lindholm J; Hamberg H; Porwit A; Elmberger G; Hoog A; Kanter L; Eriksson E; Stemme S; Orrego A; Saft L; Petersson F; De la Torre M; Ekstrom C; Astrom K; Rundgren A; Djokic M; Chandanos E; Lenander C; Machado M; Nilsson P; Mattsson L
Article: ENDOCRINE-RELATED CANCER. 2006;13(2):509-523
Loss of parafibromin expression in a subset of parathyroid adenomas
Juhlin C; Larsson C; Yakoleva T; Leibiger I; Leibiger B; Alimov A; Weber G; Hoog A; Villablanca A
Article: TUMOR BIOLOGY. 2006;27(4):211-220
Molecular markers for discrimination of benign and malignant follicular thyroid tumors
Fryknas M; Wickenberg-Bolin U; Goransson H; Gustafsson MG; Foukakis T; Lee J-J; Landegren U; Hoog A; Larsson C; Grimelius L; Wallin G; Pettersson U; Isaksson A
Article: EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES. 2005;113(9):516-521
Lack of mutations in the TSHr and Gsα genes in TSHr antibody negative Graves' disease
Elgadi A; Frisk T; Larsson C; Wallin G; Höög A; Zedenius J; Norgren S
Article: ANTICANCER RESEARCH. 2005;25(4):3099-3102
Intraductal serrated adenoma of the pancreas.: A case report
Rubio CA; Grimelius L; Von Sivers K; Höög A
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2005;152(3):459-470
Distinction in gene expression profiles demonstrated in parathyroid adenomas by high-density oligoarray technology
Forsberg L; Björck E; Hashemi J; Zedenius J; Höög A; Farnebo LO; Reimers M; Larsson C
Article: ONCOGENE. 2005;24(8):1467-1476
Expression profiling reveals a distinct transcription signature in follicular thyroid carcinomas with a PAX8-PPARγ fusion oncogene
Lui WO; Foukakis T; Lidén J; Thoppe SR; Dwight T; Höög A; Zedenius J; Wallin G; Reimers M; Larsson C
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2005;26(1):141-149
Molecular cytogenetic characterization of primary cultures and established cell lines from non-medullary thyroid tumors
Foukakis T; Thoppe SR; Lagercrantz S; Dwight T; Weng WH; Svensson A; Höög A; Zedenius J; Wallin G; Lui WO; Larsson C
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2004;151(1):73-85
Postoperative differentiation between unilateral adrenal adenoma and bilateral adrenal hyperplasia in primary aldosteronism by mRNA expression of the gene CYP11B2
Enberg U; Volpe C; Höög A; Wedell A; Farnebo LO; Thorén M; Hamberger B
Article: JOURNAL OF MEDICAL GENETICS. 2004;41(3):e32-32
Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP) -: art. no. e32
Villablanca A; Calender A; Forsberg L; Höög A; Cheng JD; Petillo D; Bauters C; Kahnoski K; Ebeling T; Salmela P; Richardson AL; Delbridge L; Meyrier A; Proye C; Carpten JD; Teh BT; Robinson BG; Larsson C
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2003;278(50):49685-49690
High extracellular Ca²⁺ hyperpolarizes human parathyroid cells via Ca²⁺-activated K⁺ channels
Välimäki S; Höög A; Larsson C; Farnebo LO; Bränström R
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2003;88(9):4440-4445
Involvement of the PAX8/peroxisome proliferator-activated receptor γ rearrangement in follicular thyroid tumors
Dwight T; Thoppe SR; Foukakis T; Lui WO; Wallin G; Höög A; Frisk T; Larsson C; Zedenius J
Article: THYROID. 2003;13(4):371-380
MIB-1 index in thyroid tumors:: A predictor of the clinical course in papillary thyroid carcinoma?
Kjellman P; Wallin G; Höög A; Auer G; Larsson C; Zedenius J
Article: EJSO. 2003;29(3):278-283
The management of benign and malignant pheochromocytoma and abdominal paraganglioma
Elder EE; Skog ALH; Höög A; Hamberger B
Article: MODERN PATHOLOGY. 2003;16(3):246-255
Ki-67 and hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma
Elder EE; Xu D; Höög A; Enberg U; Pisa P; Gruber A; Larsson C; Bäckdahl M
Article: NATURE GENETICS. 2002;32(4):676-680
HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome
Carpten JD; Robbins CM; Villablanca A; Forsberg L; Presciuttini S; Bailey-Wilson J; Simonds WF; Gillanders EM; Kennedy AM; Chen JD; Agarwal SK; Sood R; Jones MP; Moses TY; Haven C; Petillo D; Leotlela PD; Harding B; Cameron D; Pannett AA; Höög A; Heath H; James-Newton LA; Robinson B; Zarbo RJ; Cavaco BM; Wassif W; Perrier ND; Rosen IB; Kristoffersson U; Turnpenny PD; Farnebo LO; Besser GM; Jackson CE; Morreau H; Trent JM; Thakker RV; Marx SJ; Teh BT; Larsson C; Hobbs MR
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2002;147(3):313-322
Involvement of the MEN1 gene locus in familial isolated hyperparathyroidism
Villablanca A; Wassif WS; Smith T; Höög A; Vierimaa O; Kassem M; Dwight T; Forsberg L; Du Q; Learoyd D; Jones K; Stranks S; Juhlin C; Teh BT; Carling T; Robinson B; Larsson C
Article: GENES CHROMOSOMES & CANCER. 2002;35(1):74-80
Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer
Frisk T; Foukakis T; Dwight T; Lundberg J; Höög A; Wallin G; Eng C; Zedenius J; Larsson C
Article: GENES CHROMOSOMES & CANCER. 2002;34(3):325-332
Alterations of the SDHD gene locus in midgut carcinoids, Merkel cell carcinomas, pheochromocytomas, and abdominal paragangliomas
Kytölä S; Nord B; Elder EE; Carling T; Kjellman M; Cedermark B; Juhlin C; Höög A; Isola J; Larsson C
Article: CLINICAL ENDOCRINOLOGY. 2002;56(2):261-269
Genetic and clinical characterization of sporadic cystic parathyroid tumours.
Villablanca A; Farnebo F; Teh BT; Farnebo L-O; Höög A; Larsson C
Article: CLINICAL ENDOCRINOLOGY. 2002;56(2):259-267
Genetic and clinical characterization of sporadic cystic parathyroid tumours
Villablanca A; Farnebo F; Teh BT; Farnebo LO; Höög A; Larsson C
Article: GENES CHROMOSOMES & CANCER. 2001;32(1):43-49
Gain of 1q and loss of 9q21.3-q32 are associated with a less favorable prognosis in papillary thyroid carcinoma
Kjellman P; Lagercrantz S; Höög A; Wallin G; Larsson C; Zedenius J
Article: AMERICAN JOURNAL OF PATHOLOGY. 2001;158(5):1803-1808
Comparative genomic hybridization identifies loss of 18q22-qter as an early and specific event in tumorigenesis of midgut carcinoids
Kytölä S; Höög A; Nord B; Cedermark B; Frisk T; Larsson C; Kjellman M
Article: APMIS. 2001;109(2):127-140
Insulin-like growth factor-II in endocrine pancreatic tumours -: Immmunohistochemical, biochemical and in situ hybridization findings
Höög A; Kjellman M; Nordqvist ACS; Höög CM; Juhlin C; Falkmer S; Schalling M; Grimelius L
Article: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2000;6(4):469-474
Expression analysis of RET and the GDNF/GFRa-1 and NTN/GFRa-2 ligand complexes in pheochromocytomas and paragangliomas
Edström E; Frisk T; Farnebo F; Höög A; Bäckdahl M; Larsson C
Article: GENES CHROMOSOMES & CANCER. 2000;29(1):83-87
Chromosomal alterations in human pancreatic endocrine tumors
Stumpf E; Aalto Y; Höög A; Kjellman M; Otonkoski T; Knuutila S; Andersson LC
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2000;142(6):643-649
Expression of RET and its ligand complexes, GDNF/GFRalpha-1 and NTN/GFRalpha-2, in medullary thyroid carcinomas
Frisk T; Farnebo F; Zedenius J; Grimelius L; Höög A; Wallin G; Larsson C
Article: METABOLISM-CLINICAL AND EXPERIMENTAL. 2000;49(5):657-661
Treatment with diazoxide causes prolonged improvement of β-cell function in rat islets transplanted to a diabetic environment
Hiramatsu S; Höög A; Möller C; Grill V
Article: JOURNAL OF ENDOCRINOLOGY. 2000;165(2):245-251
Insulin-like growth factor II in human fetal pancreas and its co-localization with the major islet hormones:: comparison with adult pancreas
Portela-Gomes GM; Höög A
Article: AMERICAN JOURNAL OF PATHOLOGY. 2000;156(2):651-659
Comparative genomic hybridization reveals frequent losses of chromosomes 1p and 3q in pheochromocytomas and abdominal paragangliomas, suggesting a common genetic etiology
Edström E; Mahlamäki E; Nord B; Kjellman M; Karhu R; Höög A; Goncharov N; Teh BT; Bäckdahl M; Larsson C
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1999;84(10):3775-3780
Alternative genetic pathways in parathyroid tumorigenesis
Farnebo F; Kytölä S; Teh BT; Dwight T; Wong FK; Höög A; Elvius M; Wassif WS; Thompson NW; Farnebo LO; Sandelin K; Larsson C
Article: WORLD JOURNAL OF SURGERY. 1999;23(3):237-242
Gelatinase A and membrane-type 1 matrix metalloproteinase mRNA:: Expressed in adrenocortical cancers but not in adenomas
Kjellman M; Enberg U; Höög A; Larsson C; Holst M; Farnebo LO; Sato H; Bäckdahl M
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1999;84(2):730-735
Genotyping of adrenocortical tumors:: Very frequent deletions of the MEN1 locus in 11q13 and of a 1-centimorgan region in 2p16
Kjellman M; Roshani L; Teh BT; Kallioniemi OP; Höög A; Gray S; Farnebo LO; Holst M; Bäckdahl M; Larsson C
Article: HISTOCHEMISTRY AND CELL BIOLOGY. 1999;111(1):33-37
Characterisation of endothelin-1-related protein in human adrenal cortex and in cortical lesions
Li Q; Grimelius L; Höög A; Johansson H; Kjellman M; Larsson A
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1998;83(8):2627-2630
Alterations of the MEN1 gene in sporadic parathyroid tumors
Farnebo F; Teh BT; Kytölä S; Svensson A; Phelan C; Sandelin K; Thompson NW; Höög A; Weber G; Farnebo LO; Larsson C
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1998;83(6):2114-2120
Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21-q32 in a subset of families
Teh BT; Farnebo F; Twigg S; Höög A; Kytölä S; Korpi-Hyövälti E; Wong FK; Nordenström J; Grimelius L; Sandelin K; Robinson B; Farnebo LO; Larsson C
Article: PATHOLOGY RESEARCH AND PRACTICE. 1998;194(1):11-23
Prognosticating tools in primary neuroendocrine (Merkel-cell) carcinomas of the skin: Histopathological subdivision, DNA cytometry, cell proliferation analyses (Ki-67-immunoreactivity) and NCAM immunohistochemistry. A clinicopathological study in 25 patients
Parrado C; Bjornhagen V; Eusebi V; Falkmer UG; Hoog A; Garcia-Caballero T; de Vargas IP; Falkmer S
Article: ULTRASTRUCTURAL PATHOLOGY. 1997;21(5):457-466
Ultrastructural localization of insulin-like growth factor-2 (IGF-2) to the secretory granules of insulin cells: A study in normal and diabetic (GK) rats
Hoog A; Hu W; AbdelHalim SM; Falkmer S; Qing L; Grimelius L
Article: FEBS LETTERS. 1997;411(2-3):301-307
RIN14B: a pancreatic delta-cell line that maintains functional ATP-dependent K+ channels and capability to secrete insulin under conditions where it no longer secretes somatostatin
Branstrom R; Hoog A; Wahl MA; Berggren PO; Larsson O
Article: APMIS. 1997;105(6):469-482
High-molecular weight IGF-2 expression in a haemangiopericytoma associated with hypoglycaemia
Hoog A; Nordqvist ACS; Hulting AL; Falkmer UG
Article: CANCER RESEARCH. 1996;56(18):4219-4223
Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy
Kjellman M; Kallioniemi OP; Karhu R; Hoog A; Farnebo LO; Auer G; Larsson C; Backdahl M
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 1996;271(29):17453-17462
Mevalonic acid is limiting for N-linked glycosylation and translocation of the insulin-like growth factor-1 receptor to the cell surface - Evidence for a new link between 3-hydroxy-3-methylglutaryl-coenzyme A reductase and cell growth
Carlberg M; Dricu A; Blegen H; Wang M; Hjertman M; Zickert P; Hoog A; Larsson O
Article: ENDOCRINOLOGY. 1996;137(6):2415-2423
Increased amounts of a high molecular weight insulin-like growth factor II (IGF-II) peptide and IGF-II messenger ribonucleic acid in pancreatic islets of diabetic Goto-Kakizaki rats
Hoog A; SandbergNordqvist AC; AbdelHalim SM; CarlssonSkwirut C; Guenifi A; Tally M; Ostenson CG; Falkmer S; Sara VR; Efendic S; Schalling M; Grimelius L
Article: GENERAL AND DIAGNOSTIC PATHOLOGY. 1996;141(3-4):215-227
A technique for automatic/interactive assessment of the proliferating fraction of neoplastic cells in solid tumors. A methodological study on the Ki-67 immunoreactive cells in human mammary carcinomas, including a comparison with the results of conventional S-phase fraction assessments by means of DNA cytometry.
Parrado C; Falkmer UG; Höög A; Falkmer S; Ahrens O; Rius F; Grimelius L
Article: HUMAN GENETICS. 1996;97(3):299-303
Deletions of the long arm of chromosome 10 in progression of follicular thyroid tumors
Zedenius J; Wallin G; Svensson A; Bovee J; Hoog A; Backdahl M; Larsson C
Article: THYROID. 1996;6(1):1-9
Alterations of p53 and expression of WAF1/p21 in human thyroid tumors
Zedenius J; Larsson C; Wallin G; Backdahl M; Aspenblad U; Hoog A; Borresen AL; Auer G
Article: ULTRASTRUCTURAL PATHOLOGY. 1995;19(6):489-494
ULTRASTRUCTURAL-LOCALIZATION OF ENDOTHELIN-1 IN NONNEOPLASTIC, HYPERPLASTIC, AND NEOPLASTIC ADRENAL-GLAND
LI Q; GRIMELIUS L; ZHANG X; LUKINIUS A; GRONDAL S; HOOG A; JOHANSSON H
Article: HUMAN GENETICS. 1995;96(1):27-32
ALLELOTYPING OF FOLLICULAR THYROID-TUMORS
ZEDENIUS J; WALLIN G; SVENSSON A; GRIMELIUS L; HOOG A; LUNDELL G; BACKDAHL M; LARSSON C
Article: MELANOMA RESEARCH. 1995;5(2):101-106
IMMUNOHISTOCHEMICAL ANALYSIS OF THE N-RAS P21 AND THE P53 PROTEINS IN NEVI, PRIMARY TUMORS AND METASTASES OF HUMAN CUTANEOUS MALIGNANT-MELANOMA - INCREASED IMMUNOPOSITIVITY IN HEREDITARY MELANOMA
PLATZ A; RINGBORG U; GRAFSTROM E; HOOG A; LAGERLOF B
Article: PANCREAS. 1995;10(2):167-172
INTRACELLULAR DEGRADATION OF THE C-PEPTIDE OF PROINSULIN, IN A HUMAN INSULINOMA - IDENTIFICATION OF SITES OF CLEAVAGE AND EVIDENCE FOR A ROLE FOR CATHEPSIN-B
CONLON JM; HOOG A; GRIMELIUS L
Article: PANCREAS. 1995;10(2):148-153
PRESERVED BETA-CELL DENSITY IN THE ENDOCRINE PANCREAS OF YOUNG, SPONTANEOUSLY DIABETIC GOTO-KAKIZAKI (GK) RATS
GUENIFI A; ABDELHALIM SM; HOOG A; FALKMER S; OSTENSON CG
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 1992;33(4):861-869
Gene-specific promoter hypermethylation without global hypomethylation in follicular thyroid cancer
Lee J-J; Geli J; Larsson C; Wallin G; Karimi M; Zedenius J; Hoog A; Foukakis T
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 1992;34(2):481-492
Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-β in parathyroid carcinomas
Juhlin CC; Haglund F; Villablanca A; Forsberg L; Sandelin K; Branstrom R; Larsson C; Hoog A
Visa fler

Alla övriga publikationer

Review: CANCERS. 2022;14(9):2210
Metastatic Neuroendocrine Neoplasms of Unknown Primary: Clues from Pathology Workup
Juhlin CC; Zedenius J; Hoog A
Letter: CLINICAL ENDOCRINOLOGY. 2010;73(4):552-553
Lack of S37A CTNNB1/β-catenin mutations in a Swedish cohort of 98 parathyroid adenomas
Haglund F; Andreasson A; Nilsson I-L; Hoog A; Larsson C; Juhlin CC
Review: INTERNATIONAL JOURNAL OF ENDOCRINOLOGY. 2010;2010:324964-5
Parafibromin as a Diagnostic Instrument for Parathyroid Carcinoma-Lone Ranger or Part of the Posse?
Juhlin CC; Hoog A
Published conference paper: SURGERY. 2005;138(6):1087-1094
Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy
Velázquez-Fernández D; Laurell C; Geli J; Höög A; Odeberg J; Kjellman M; Lundeberg J; Hamberger B; Nilsson P; Bäckdahl M
Published conference paper: WORLD JOURNAL OF SURGERY. 2002;26(8):965-971
Loss of heterozygosity on the short arm of chromosome 1 in pheochromocytoma and abdominal paraganglioma
Elder EE; Nord B; Carling T; Juhlin C; Bäckdahl M; Höög A; Larsson C
Published conference paper: BRITISH JOURNAL OF SURGERY. 2001;88(4):557-563
Expression of the RET proto-oncogene in papillary thyroid carcinoma and its correlation with clinical outcome
Kjellman P; Learoyd DL; Messina M; Weber G; Höög A; Wallin G; Larsson C; Robinson BG; Zedenius J
Letter: JOURNAL OF MEDICAL GENETICS. 2001;38(3):185-189
Founder effect in multiple endocrine neoplasia type 1 (MEN 1) in Finland
Kytölä S; Villablanca A; Ebelings T; Nord B; Larsson C; Höög A; Wong FK; Välimäki M; Vierimaa O; Teh BT; Salmela PI; Leisti J
Published conference paper: SURGERY. 1998;124(6):1094-1098
Decreased expression of calcium-sensing receptor messenger ribonucleic acids in parathyroid adenomas
Farnebo F; Höög A; Sandelin K; Larsson C; Farnebo LO
Thesis / dissertation: 1997
High-molecular-weight insulin-like growth factor 2 : immunohistochemical, ultrastructural and biochemical findings in insulin cells under normal, diabetic, and neoplastic conditions, and its role in non-islet cell tumour hypoglycaemia
Höög, Anders

Anställningar

Anknuten till Undervisning/Handledning, Onkologi-Patologi, Karolinska Institutet, 2022-2025

Examina och utbildning

Docent, klinisk patologi, Karolinska institutet, 2011

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI